InvestorsHub Logo
Followers 61
Posts 9563
Boards Moderated 0
Alias Born 03/29/2015

Re: koman post# 34784

Thursday, 05/14/2015 10:25:45 PM

Thursday, May 14, 2015 10:25:45 PM

Post# of 708089
For inoperable tumors something that works is appealing for commercialization.

Right now, patients who are this bad do not have many options.

So provided DCVax works, most people would rather pay say $100k for something that grants extension of life without side effects and maybe a cure than to pay even $60k for something that has hideous side effects, does not extend life by as much and has little to no chance to provide a cure.

Last Week Tonight had a good show criticizing the cozy relationship between doctors and pharmaceutical companies that might help explain why NWBO is having trouble breaking through.

I wouldn't expect much from ASCO but if we get something new, that would be great.

But I learned from last year where pretty much the only information I got on what was happening at NWBO's vaunted gigantic booth was from a lousy photo provided by Adam Feuerstein. You would think NWBO could have had an intern snap a few higher quality pictures and put them up on social media.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News